Drug Database
Back to search

United States· US:62332-404_95bac104-64eb-4a09-9c98-ed82ba912ab6

NADOLOL

A nadolol product containing nadolol, registered in United States by Alembic Pharmaceuticals Inc.. The same ATC class is registered in 6 of our 19 countries.

ATC C07AA12US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedNADOLOLATCC07AA12REGISTER NO.US:62332-404_95bac104…PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nadololAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nadolol is registered in 6 of 19 countries.

Countries holding a registration under ATC C07AA12 (nadolol), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 3 of them publish a price we can compare per daily dose
Search nadolol products by name

Nadolol · ATC C07AA12

6 / 19 countries

  • Canada
  • Franceprice
  • Japan
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nadolol costs, country by country.

Normalised to the WHO defined daily dose (0.16 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Nadolol · price per daily dose (0.16 g)

USD · FX 28 Sept 2026

  • FR France$0.84
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
NADOLOL
Manufacturer
Alembic Pharmaceuticals Inc.
Country
United States (US)
ATC code
C07AA12
ATC class
Nadolol
Defined daily dose
0.16 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    62332-404-30
  • ndc11
    62332-404-31
  • ndc11
    62332-404-91
  • ndc11
    6233240430
    30 TABLET in 1 BOTTLE (62332-404-30)
  • ndc11
    6233240431
    100 TABLET in 1 BOTTLE (62332-404-31)
  • ndc11
    6233240491
    1000 TABLET in 1 BOTTLE (62332-404-91)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

302 interactions on record for nadolol.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nadolol against other medicinesHow interaction checks work

Nadolol · interactions on record

302 records

  • 31 severe
  • 164 moderate
  • 28 minor
  • 79 info

Most severe, free to view

  • DolasetronA04AA04severe
  • EpinephrineB02BC09severe
  • EpinephrineC01CA24severe
  • OrciprenalinC01CA29severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nadolol in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nadolol products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • France · Corgard
  • United Kingdom (Northern Ireland) · Nadolol Neon Healthcare
  • Italy · Nadololo Cheplapharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d8ee0602-0d48-490f-92d5-43282946678c
GET /v1/drugs/d8ee0602-0d48-490f-92d5-43282946678c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "80",
  "substance": "NADOLOL",
  "productndc": "62332-404",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA211763",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about nadolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console